vs

Side-by-side financial comparison of CLEANSPARK, INC. (CLSK) and Doximity, Inc. (DOCS). Click either name above to swap in a different company.

Doximity, Inc. is the larger business by last-quarter revenue ($185.1M vs $181.2M, roughly 1.0× CLEANSPARK, INC.). Doximity, Inc. runs the higher net margin — 33.3% vs -209.0%, a 242.3% gap on every dollar of revenue. On growth, CLEANSPARK, INC. posted the faster year-over-year revenue change (11.6% vs 9.8%). Over the past eight quarters, CLEANSPARK, INC.'s revenue compounded faster (106.4% CAGR vs 25.2%).

CleanSpark, Inc. is a U.S.-headquartered sustainable technology company operating two core business segments: low-carbon Bitcoin mining powered primarily by renewable and stranded energy resources, and end-to-end microgrid design, deployment, and operation services for commercial, industrial, and public sector clients across North America.

Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.

CLSK vs DOCS — Head-to-Head

Bigger by revenue
DOCS
DOCS
1.0× larger
DOCS
$185.1M
$181.2M
CLSK
Growing faster (revenue YoY)
CLSK
CLSK
+1.9% gap
CLSK
11.6%
9.8%
DOCS
Higher net margin
DOCS
DOCS
242.3% more per $
DOCS
33.3%
-209.0%
CLSK
Faster 2-yr revenue CAGR
CLSK
CLSK
Annualised
CLSK
106.4%
25.2%
DOCS

Income Statement — Q1 FY2026 vs Q3 FY2026

Metric
CLSK
CLSK
DOCS
DOCS
Revenue
$181.2M
$185.1M
Net Profit
$-378.7M
$61.6M
Gross Margin
47.2%
89.9%
Operating Margin
-174.7%
38.9%
Net Margin
-209.0%
33.3%
Revenue YoY
11.6%
9.8%
Net Profit YoY
-253.5%
-18.1%
EPS (diluted)
$0.31

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
CLSK
CLSK
DOCS
DOCS
Q4 25
$181.2M
$185.1M
Q3 25
$168.5M
Q2 25
$145.9M
Q1 25
$138.3M
Q4 24
$168.6M
Q3 24
$89.3M
$136.8M
Q2 24
$104.1M
$126.7M
Q1 24
$111.8M
$118.1M
Net Profit
CLSK
CLSK
DOCS
DOCS
Q4 25
$-378.7M
$61.6M
Q3 25
$62.1M
Q2 25
$53.3M
Q1 25
$62.5M
Q4 24
$75.2M
Q3 24
$-62.2M
$44.2M
Q2 24
$-236.2M
$41.4M
Q1 24
$126.7M
$40.6M
Gross Margin
CLSK
CLSK
DOCS
DOCS
Q4 25
47.2%
89.9%
Q3 25
90.3%
Q2 25
89.2%
Q1 25
89.5%
Q4 24
91.6%
Q3 24
36.0%
90.0%
Q2 24
56.6%
89.3%
Q1 24
69.3%
89.4%
Operating Margin
CLSK
CLSK
DOCS
DOCS
Q4 25
-174.7%
38.9%
Q3 25
37.8%
Q2 25
37.4%
Q1 25
35.2%
Q4 24
47.4%
Q3 24
-73.5%
38.8%
Q2 24
-239.2%
36.4%
Q1 24
35.5%
Net Margin
CLSK
CLSK
DOCS
DOCS
Q4 25
-209.0%
33.3%
Q3 25
36.8%
Q2 25
36.5%
Q1 25
45.2%
Q4 24
44.6%
Q3 24
-69.6%
32.3%
Q2 24
-226.9%
32.7%
Q1 24
113.4%
34.4%
EPS (diluted)
CLSK
CLSK
DOCS
DOCS
Q4 25
$0.31
Q3 25
$0.31
Q2 25
$0.27
Q1 25
$0.31
Q4 24
$0.37
Q3 24
$0.22
Q2 24
$0.21
Q1 24
$0.20

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
CLSK
CLSK
DOCS
DOCS
Cash + ST InvestmentsLiquidity on hand
$458.1M
$64.8M
Total DebtLower is stronger
$1.8B
Stockholders' EquityBook value
$1.4B
$979.3M
Total Assets
$3.3B
$1.2B
Debt / EquityLower = less leverage
1.29×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
CLSK
CLSK
DOCS
DOCS
Q4 25
$458.1M
$64.8M
Q3 25
$169.2M
Q2 25
$137.3M
Q1 25
$209.6M
Q4 24
$165.3M
Q3 24
$121.2M
$184.2M
Q2 24
$126.1M
$111.4M
Q1 24
$96.8M
Total Debt
CLSK
CLSK
DOCS
DOCS
Q4 25
$1.8B
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$7.2M
Q2 24
$1.3M
Q1 24
$5.1M
Stockholders' Equity
CLSK
CLSK
DOCS
DOCS
Q4 25
$1.4B
$979.3M
Q3 25
$1.1B
Q2 25
$1.0B
Q1 25
$1.1B
Q4 24
$1.0B
Q3 24
$1.8B
$961.2M
Q2 24
$1.4B
$913.6M
Q1 24
$1.5B
$901.4M
Total Assets
CLSK
CLSK
DOCS
DOCS
Q4 25
$3.3B
$1.2B
Q3 25
$1.3B
Q2 25
$1.2B
Q1 25
$1.3B
Q4 24
$1.2B
Q3 24
$2.0B
$1.1B
Q2 24
$1.5B
$1.1B
Q1 24
$1.5B
$1.1B
Debt / Equity
CLSK
CLSK
DOCS
DOCS
Q4 25
1.29×
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
0.00×
Q2 24
0.00×
Q1 24
0.00×

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
CLSK
CLSK
DOCS
DOCS
Operating Cash FlowLast quarter
$-161.1M
$60.9M
Free Cash FlowOCF − Capex
$-198.1M
FCF MarginFCF / Revenue
-109.3%
Capex IntensityCapex / Revenue
20.4%
Cash ConversionOCF / Net Profit
0.99×
TTM Free Cash FlowTrailing 4 quarters
$-626.9M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
CLSK
CLSK
DOCS
DOCS
Q4 25
$-161.1M
$60.9M
Q3 25
$93.9M
Q2 25
$62.1M
Q1 25
$98.5M
Q4 24
$65.2M
Q3 24
$-233.7M
$68.3M
Q2 24
$-58.4M
$41.2M
Q1 24
$-44.8M
$63.9M
Free Cash Flow
CLSK
CLSK
DOCS
DOCS
Q4 25
$-198.1M
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
$-299.8M
Q2 24
$-68.7M
Q1 24
$-60.3M
FCF Margin
CLSK
CLSK
DOCS
DOCS
Q4 25
-109.3%
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
-335.8%
Q2 24
-66.0%
Q1 24
-54.0%
Capex Intensity
CLSK
CLSK
DOCS
DOCS
Q4 25
20.4%
Q3 25
Q2 25
Q1 25
0.0%
Q4 24
0.0%
Q3 24
74.0%
0.0%
Q2 24
9.9%
0.0%
Q1 24
13.8%
0.0%
Cash Conversion
CLSK
CLSK
DOCS
DOCS
Q4 25
0.99×
Q3 25
1.51×
Q2 25
1.16×
Q1 25
1.58×
Q4 24
0.87×
Q3 24
1.55×
Q2 24
1.00×
Q1 24
-0.35×
1.57×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

CLSK
CLSK

Segment breakdown not available.

DOCS
DOCS

Subscription$175.4M95%
Service Other$9.7M5%

Related Comparisons